Veterinary radiology AI · Cytology and pathology AI · Livestock pharmaceutical AI · Pet insurance claim AI
Prompt injection in veterinary and animal health AI
Veterinary and animal health AI has become the diagnostic and operational backbone of small-animal clinical practice, livestock management, and companion-animal insurance at tens of thousands of veterinary facilities worldwide: IDEXX Laboratories’ AI portfolio — including IDEXX AI Radiometry for veterinary digital radiograph interpretation and IDEXX VetConnect PLUS AI for diagnostic result integration — is deployed at over 65,000 veterinary practices globally, processing digital radiograph images and DICOM files through AI-assisted radiology report generation tools that inform clinical decisions ranging from fracture identification and cardiomegaly grading to neoplastic mass detection and pulmonary pattern characterisation, Zoetis — the world’s largest dedicated animal health company by revenue at $8.5 billion–plus in 2024 — operates AI-assisted diagnostic platforms for both companion animal and livestock segments, integrating AI pathology and laboratory result interpretation with its global diagnostic services infrastructure that spans reference laboratories, on-farm diagnostics, and point-of-care testing across more than 100 countries, Antech Diagnostics — owned by Mars Veterinary Health and operating over 2,500 veterinary reference laboratories and diagnostic imaging centres globally — processes digitised histopathology slide images and cytology sample photographs through AI-assisted diagnostic laboratory tools that classify neoplastic, inflammatory, and infectious conditions from tissue samples submitted by veterinarians in private practice, VCA Animal Hospital AI — operating more than 1,000 animal hospitals across the US and Canada under the Mars Veterinary Health umbrella — processes in-clinic imaging studies and external specialist consultation DICOM files through AI-assisted diagnostic decision support tools integrated with its hospital management systems, Banfield Pet Hospital AI — operating over 1,000 hospitals in partnership with PetSmart across the US — deploys AI-assisted preventive care and diagnostic screening tools through its hospital electronic medical record systems, Merck Animal Health AI and Elanco Animal Health AI — both major animal pharmaceutical companies with multibillion-dollar livestock product portfolios — utilise AI-assisted pharmaceutical compounding compliance and livestock drug use documentation tools in partnership with USDA FSIS-regulated livestock operations, and Boehringer Ingelheim Animal Health AI processes livestock vaccination and pharmaceutical batch record documentation through AI-assisted compliance management platforms for producers in swine, poultry, and cattle segments. These veterinary and animal health AI platforms share a structural vulnerability that creates a significant adversarial image injection exposure surface: each depends on images submitted through clinical, laboratory, or operational workflows where the submitting party — a veterinary practice staff member, a livestock producer, a compounding pharmacy, a veterinary diagnostic laboratory client, or a pet owner filing an insurance claim — has direct access to the AI submission pathway and has a clinical, financial, or regulatory interest in the AI’s diagnostic, compliance, or claim assessment output. Adversarially crafted images submitted through any of these pathways can suppress fracture, neoplasia, and cardiomegaly findings in veterinary radiology AI, conceal malignancy markers in cytology and pathology AI, mask livestock drug residue risks in pharmaceutical compliance AI, and inflate injury severity in pet insurance claim assessment AI — with consequences spanning AVMA veterinary ethics violations, AAVLD diagnostic accreditation standards failures, USDA FSIS livestock food safety enforcement, FDA CVM regulatory action, AMDUCA extralabel drug use violations, and insurance fraud prosecution in all 50 states.
TL;DR
Veterinary and animal health AI platforms — IDEXX AI Radiometry, IDEXX VetConnect PLUS AI, Zoetis AI diagnostics, Antech Diagnostics AI cytology, VCA Animal Hospital AI, Banfield Pet Hospital AI, Heliogen Health veterinary AI, Vetsource prescription management AI, ClienTrax/AVImark/ImproMed practice management AI, Merck Animal Health AI, Elanco Animal Health AI livestock, Boehringer Ingelheim Animal Health AI — process digital radiograph and DICOM images, cytology slide scans, livestock pharmaceutical batch record photographs, and pet insurance claim injury photographs through AI radiology interpretation, pathology classification, pharmaceutical compliance, and insurance claim assessment pipelines. Adversarially crafted images submitted through IDEXX AI radiograph portals, Antech cytology submission interfaces, Zoetis/Merck livestock pharmaceutical management platforms, and Trupanion/Nationwide pet insurance claim photograph portals can suppress fracture and neoplastic findings, conceal malignancy from cytology AI, mask drug residue risks in food-safety livestock compounding records, and inflate claim severity in pet insurance AI assessments. Glyphward scans each image at the ingestion boundary with a threshold of ≥ 55 for all veterinary and animal health AI contexts (AVMA ethics, AAVLD diagnostic standards, USDA FSIS food safety, pet insurance fraud). Free tier — 10 scans/day, no card required.
Four adversarial injection surfaces in veterinary and animal health AI
1. Veterinary radiology and digital X-ray AI injection (IDEXX AI Radiometry, VetCT AI, Vet-AI radiograph interpretation)
Veterinary radiology AI processes digital radiograph images, DICOM files converted to JPEG or PNG, and ultrasound image screenshots submitted through AI-assisted veterinary radiograph interpretation platforms to generate radiology reports that identify musculoskeletal injuries, thoracic and abdominal abnormalities, cardiac enlargement, pulmonary infiltrates, and oncological masses for small-animal practitioners. IDEXX Laboratories’ AI Radiometry platform — integrated into the IDEXX Digital Radiography (DR) system used at tens of thousands of veterinary practices — processes digital radiograph images captured through IDEXX Equiview and standard veterinary digital radiography detector panels, applying AI-assisted pattern recognition to generate structured radiology assessment reports that flag abnormalities including fractures, cardiomegaly, pneumothorax, pleural effusion, pulmonary infiltrates, and soft-tissue masses for veterinarian review. VetCT AI, a specialist veterinary teleradiology platform, processes DICOM files submitted by general practice veterinarians through a cloud-based teleradiology portal to board-certified veterinary radiologists who use AI-assisted triage and preliminary assessment tools to prioritise the case queue and generate specialist radiology reports. Vet-AI and similar AI radiograph interpretation services process digital radiograph image files submitted through API integrations with practice management systems including AVImark, ImproMed, and ClienTrax, providing AI-assisted radiograph interpretation at practices that do not have access to board-certified veterinary radiologists on staff or through a teleradiology service.
The digital radiograph image and DICOM file submission pathway is the adversarial injection surface: JPEG and PNG radiograph images exported from the practice’s digital radiography system and submitted through the IDEXX AI Radiometry cloud upload portal, the VetCT AI DICOM submission gateway, or the Vet-AI API integration point for AI-assisted radiology interpretation. An adversarially crafted digital radiograph image — in which pixel perturbations applied to the region of the radiograph showing a fracture callus, a soft-tissue mass with radiodense margins, an enlarged cardiac silhouette indicating cardiomegaly, or an increased pulmonary opacity pattern indicating pneumothorax — cause the IDEXX AI Radiometry or VetCT AI to generate a radiology report that does not flag the abnormality, characterising the film as within normal limits or attributing the relevant region to normal anatomical variation. The adversarial suppression motivation in veterinary radiology AI is clinical outcome driven: a radiology report that does not flag a neoplastic mass defers the oncological workup that would reveal the diagnosis, a report that misses a fracture defers the immobilisation and surgical intervention, and a report that misses cardiomegaly defers the cardiac evaluation and treatment that could prolong the animal’s life. The motivation for suppression may be a client who has already been told a diagnosis is likely and does not want it confirmed, a practice owner managing client relationships by avoiding difficult conversations, or a malicious actor with access to the image submission pathway at a high-volume veterinary practice.
Regulatory and professional consequences of adversarially suppressed veterinary radiology AI findings operate through AVMA and state veterinary board frameworks that impose affirmative diagnostic accuracy obligations on licensed veterinarians. The AVMA Guidelines for Veterinary Telemedicine (2021) require that veterinary telemedicine services — including AI-assisted radiograph interpretation services that constitute telemedicine under state veterinary practice act definitions — meet the same standard of care as in-person veterinary diagnosis, and that the veterinarian-client-patient relationship (VCPR) includes an obligation to provide accurate diagnostic assessment. State veterinary practice acts in all 50 states impose professional licensing obligations on veterinarians that include the duty to perform or obtain accurate diagnostic workups when a patient presents with signs or history consistent with a serious condition — a radiograph AI that suppresses a fracture or neoplastic finding may contribute to a diagnostic failure that constitutes veterinary malpractice under state law. Where the adversarial image manipulation is part of a pet insurance fraud scheme — suppressing the radiograph finding in the AI report to avoid a pre-existing condition exclusion determination — the manipulation may also constitute insurance fraud under state insurance fraud statutes. FTC Section 5 (15 USC § 45) deceptive practices authority extends to AI-assisted diagnostic services that misrepresent the completeness or accuracy of their diagnostic outputs. Threshold: 55 for veterinary radiology and digital X-ray AI (AVMA telemedicine guidelines, state VCPR requirements, AAVLD diagnostic standards, FTC Section 5, pet insurance fraud).
2. Veterinary pathology slide and cytology AI injection (IDEXX AI cytology, Antech Diagnostics AI, Zoetis AI pathology)
Veterinary pathology and cytology AI processes digitised histopathology slide images, cytology sample photograph scans, and blood smear image uploads submitted through AI-assisted veterinary diagnostic laboratory platforms to classify tissue and cellular samples as malignant, benign, inflammatory, infectious, or reactive — generating AI-assisted cytology and pathology reports that determine whether a veterinarian should proceed with oncological staging and treatment, additional diagnostic testing, or conservative monitoring. IDEXX’s AI cytology platform — integrated into the IDEXX Reference Laboratories network that serves over 65,000 veterinary practices — processes digitised cytology slide images from fine-needle aspirate (FNA) samples of lymph nodes, skin masses, splenic masses, and body cavity effusions, applying AI-assisted cell classification to generate preliminary cytology reports that assist board-certified veterinary clinical pathologists in their review and final diagnosis. Antech Diagnostics AI — operating over 2,500 veterinary reference laboratories globally under Mars Veterinary Health — processes histopathology slide scans and cytology photograph images for veterinary practices and specialty hospitals, using AI-assisted tissue classification to triage high-volume slide reading queues and generate AI-assisted preliminary diagnoses for pathologist review. Zoetis AI pathology tools process blood smear scans and cytology sample photographs for livestock diagnostic applications as well as companion animal diagnostics, integrating AI-assisted cell count and morphology classification with the Zoetis Diagnostics laboratory information management system used at veterinary reference laboratories globally.
The cytology slide scan and histopathology photograph submission pathway is the adversarial injection surface: digitised glass slide images and photograph scans of cytology preparations submitted through the IDEXX Reference Laboratories digital submission portal, the Antech Diagnostics AI laboratory information system, or the Zoetis Diagnostics API for AI-assisted pathology classification. An adversarially crafted cytology slide scan — in which pixel perturbations are applied to the cellular regions of the image that display the morphological hallmarks of malignancy — increased nuclear-to-cytoplasmic ratio, hyperchromatic nuclei with prominent nucleoli, anaplastic cell features including multinucleation and atypical mitotic figures, and irregular nuclear membranes — cause the IDEXX AI cytology or Antech Diagnostics AI to classify the sample as benign reactive lymphoid hyperplasia, benign reactive mesothelial cells, or a non-diagnostic sample requiring resubmission, when the actual cytology preparation demonstrates a high-grade lymphoma, carcinoma, or sarcoma requiring immediate oncological staging and treatment initiation. The adversarial suppression motivation in veterinary cytology AI can be financial — suppressing a malignancy finding to avoid the cost of oncology treatment — or may operate through a malicious actor at the laboratory submission pathway for a veterinary practice or boarding/breeding facility with repeated high-value patients.
AAVLD (American Association of Veterinary Laboratory Diagnosticians) laboratory accreditation standards impose diagnostic accuracy requirements on veterinary reference laboratories that process AI-assisted cytology and pathology reports, including requirements that AI-assisted preliminary assessments be reviewed by a board-certified veterinary clinical pathologist before the report is released to the submitting veterinarian. A cytology AI that is adversarially manipulated to produce a benign preliminary classification may cause the pathologist’s review to be perfunctory — because the preliminary AI classification anchors the pathologist’s assessment and the pathologist may not independently re-examine the digitised slide with the same scrutiny they would apply to a slide flagged by the AI as suspicious. The AVMA Principles of Veterinary Medical Ethics (Section IV, “Responsibilities to the Public and the Profession”) impose ethical obligations on veterinarians and veterinary service providers — including diagnostic laboratories — to provide diagnostic assessments that meet the applicable standard of care and to avoid misrepresentation of diagnostic findings. USDA APHIS diagnostic reporting requirements under 9 CFR Part 55 impose mandatory reporting obligations on veterinary diagnostic laboratories for certain zoonotic diseases — where the adversarially manipulated cytology AI suppresses findings consistent with a reportable zoonotic pathogen, the failure to report may constitute a federal regulatory violation. FDA CVM (Center for Veterinary Medicine) veterinary device guidance applicable to AI-assisted veterinary diagnostic tools addresses the accuracy and validation requirements for AI diagnostic devices in veterinary medicine. Threshold: 55 for veterinary pathology slide and cytology AI (AAVLD accreditation standards, AVMA ethics, state veterinary board malpractice, USDA APHIS zoonotic disease reporting, FDA CVM device guidance).
3. Livestock pharmaceutical batch record and compounding AI injection (Zoetis AI livestock, Merck Animal Health AI, Elanco Poultry AI, USDA FSIS AI)
Livestock pharmaceutical batch record and compounding AI processes pharmaceutical compounding record photographs, drug batch record document scans, and veterinary drug label photographs submitted through AI-assisted livestock pharmaceutical management and USDA food safety compliance platforms to extract active pharmaceutical ingredient (API) concentrations, verify batch specification compliance, and generate pharmaceutical use records for livestock operations subject to USDA FSIS Residue Avoidance Program requirements. Zoetis — whose livestock pharmaceutical portfolio spans swine, poultry, cattle, and aquaculture and includes major products such as Draxxin (tulathromycin), Excede (ceftiofur), and Advocin (danofloxacin) — operates AI-assisted pharmaceutical management tools for livestock producers that process compounding batch record photographs and drug use documentation through AI-assisted compliance verification platforms integrated with veterinary prescription management systems. Merck Animal Health AI — whose livestock portfolio includes Nuflor (florfenicol), Baytril (enrofloxacin), and Safeguard (fenbendazole) — processes pharmaceutical batch record documents and drug concentration verification photographs through AI-assisted livestock pharmaceutical compliance tools for large integrated livestock producers. Elanco Animal Health AI — with a significant poultry and swine pharmaceutical portfolio including Tylan (tylosin) and Corid (amprolium) — processes drug batch records and compounding documentation for AI-assisted pharmaceutical compliance management in poultry integrators and contract swine production operations.
The pharmaceutical compounding batch record photograph and drug label scan submission pathway is the adversarial injection surface: photographs of paper compounding batch records, drug concentration verification printouts, and veterinary drug label images submitted through Zoetis AI, Merck Animal Health AI, or Elanco AI pharmaceutical compliance platforms for AI-assisted API concentration extraction and specification compliance verification. An adversarially crafted compounding batch record photograph — in which pixel perturbations applied to the printed drug concentration field — such as the active oxytetracycline concentration in milligrams per litre in a medicated water system record, the injectable tylosin concentration per millilitre in a compounded product, or the withdrawal time calculation based on the drug concentration and species body weight — cause the Zoetis AI or Merck Animal Health AI to extract a within-specification API concentration from the batch record image when the actual batch record documents an out-of-specification compounding event that results in a drug residue violation risk in animals destined for slaughter. The adversarial manipulation motivation in livestock pharmaceutical compliance AI is food safety regulatory driven: USDA FSIS residue violations — where tissue samples from slaughtered animals contain drug residues above the established safe residue tolerance — generate FSIS Notice detentions, facility holds, carcass condemnation, and in chronic cases, loss of USDA inspection approval that can shut down a livestock production operation.
USDA FSIS regulatory consequences for adulterated livestock are among the most serious in agricultural food safety law. The USDA FSIS National Residue Program (9 CFR Part 310, FSIS Notice 12-25) conducts residue testing on harvested livestock carcasses, and animals found to contain violative drug residues above safe tolerance levels established under 21 CFR Part 556 are condemned and the producing operation is placed on a FSIS Residue Repeat Violator List — generating increased testing frequency that creates operational disruption and reputational consequences for the livestock producer. The AMDUCA (Animal Medicinal Drug Use Clarification Act of 1994, 21 USC § 360b note) and its implementing regulations at 21 CFR Part 530 govern extralabel drug use in food-producing animals and impose strict withdrawal time requirements for drugs used in livestock, with violations constituting adulteration of food under the Federal Food, Drug, and Cosmetic Act (21 USC § 342). USDA FSIS criminal prosecution for adulterated meat under the Federal Meat Inspection Act (21 USC § 621) imposes criminal penalties for the distribution of adulterated meat products, including penalties of up to 3 years imprisonment and $10,000 fine per violation for knowing introduction of adulterated meat into commerce. An adversarially manipulated livestock pharmaceutical compliance AI that generates a within-specification batch record extraction from a manipulated out-of-specification batch record photograph — causing the livestock producer to maintain animals in production through a withdrawal period that is too short for the actual drug concentration — creates a regulatory and criminal exposure pathway under USDA FSIS, AMDUCA, and the FMIA that is not eliminated by the AI mediation of the false documentation. Threshold: 55 for livestock pharmaceutical batch record and compounding AI (USDA FSIS Residue Avoidance Program, AMDUCA 21 CFR Part 530, FDA CVM NADA/ANADA, 9 CFR Part 310, FMIA 21 USC § 621).
4. Pet insurance claim photograph AI injection (Trupanion AI, Nationwide Pet Insurance AI, ASPCA Pet Health Insurance AI, Lemonade Pet AI)
Pet insurance claim photograph AI processes injury and condition photograph submissions, veterinary invoice photographs, and medical record page photographs submitted by policyholders through AI-assisted pet insurance claim assessment platforms to evaluate claim severity, verify treatment necessity, classify injury or disease type, and generate reimbursement tier determinations that are used in automated claim approval workflows. Trupanion — the largest publicly traded pet insurance provider in North America with over 950,000 enrolled pets and approximately $1 billion in annualised premium — operates AI-assisted claim processing tools that evaluate submitted veterinary invoice photographs and medical record images to classify claims by condition category and severity and generate AI-assisted eligibility and reimbursement recommendations integrated into its Express Claims system, which processes a significant percentage of eligible claims in real time at the point of payment at participating veterinary practices. Nationwide Pet Insurance — the largest US pet insurer by enrolled pet count with over 1 million policies — processes injury and condition photograph submissions through AI-assisted claim triage and assessment tools that classify submitted images by injury type and severity to route claims to automated approval, adjuster review, or veterinary specialist review queues. ASPCA Pet Health Insurance (underwritten by PTZ Insurance Agency) and Lemonade Pet Insurance — both major direct-to-consumer pet insurance providers with growing AI-assisted claim processing capabilities — process policyholder-submitted injury photographs and veterinary document scans through AI-assisted claim assessment tools integrated with their mobile claim submission workflows.
The pet insurance claim photograph submission pathway is the adversarial injection surface: injury condition photographs, surgical site images, and veterinary invoice photographs submitted by policyholders through the Trupanion Express Claims portal, the Nationwide Pet Insurance mobile claim app, the ASPCA Pet Health Insurance claim submission interface, or the Lemonade Pet AI claim chatbot for AI-assisted claim severity assessment and reimbursement tier classification. An adversarially crafted injury or surgical site photograph — in which pixel perturbations applied to the wound margin region, the tissue visualisation field, or the surgical incision documentation image cause the Trupanion AI or Nationwide Pet Insurance AI to classify a minor laceration requiring basic wound closure as a severe traumatic injury requiring extensive surgical repair, or to classify a routine dental cleaning procedure photograph as a more complex oral surgery — generates an inflated claim estimate that exceeds the reimbursement that a human claim adjuster with the original unmanipulated image would authorise. The adversarial claim inflation motivation is financial fraud: pet insurance claim fraud through image manipulation is an extension of the broader insurance fraud pattern of inflating claim severity through document manipulation — the AI mediation of the inflated claim merely replaces the human adjuster who would have been the target of the manipulated submission in a pre-AI insurance workflow.
State insurance fraud statutory consequences for pet insurance claim manipulation are substantive and broadly applicable: pet insurance fraud is prosecutable under general insurance fraud statutes in all 50 states, which criminalise the knowing submission of false or fraudulent claims or supporting documentation to an insurance company for the purpose of obtaining benefits to which the claimant is not entitled. The NAIC (National Association of Insurance Commissioners) pet insurance model regulation — adopted in more than 20 states as of 2025 — establishes standardised definitions for covered conditions and claim documentation requirements that impose additional legal structure on the pet insurance claim submission process. California DOI Fair Claims Settlement Practices regulations (10 CCR § 2695) impose specific requirements on insurers and by extension inform the claim documentation standards applicable to California policyholders. FTC Section 5 (15 USC § 45) deceptive practices authority extends to AI-assisted claim processing that misrepresents the accuracy or completeness of claim severity assessments — both from the insurer’s perspective (unfair AI denials) and potentially from a fraud investigation perspective where AI claim inflation tools are marketed or facilitated. A pet insurer that implements Glyphward pre-scan for claim photograph inputs to its Trupanion/Nationwide/Lemonade AI claim platform has a documented basis for demonstrating that it implemented a data integrity verification measure in its AI claim processing workflow — relevant to regulatory examinations by state insurance departments under the NAIC model regulation and to any insurer defence in a bad-faith insurance litigation proceeding where AI claim assessment accuracy is challenged. Threshold: 55 for pet insurance claim photograph AI (state insurance fraud statutes in all 50 states, NAIC pet insurance model regulation, California DOI 10 CCR § 2695, FTC Section 5 deceptive AI claim processing).
Integration: veterinary and animal health AI image ingestion with Glyphward pre-scan
Veterinary and animal health AI image ingestion flows from IDEXX AI Radiometry and VetCT AI DICOM upload portals, Antech Diagnostics and IDEXX Reference Laboratories cytology slide scan submission interfaces, Zoetis/Merck/Elanco livestock pharmaceutical batch record photograph APIs, and Trupanion/Nationwide/Lemonade pet insurance claim photograph submission portals into AI radiology interpretation, cytology classification, pharmaceutical compliance, and insurance claim assessment pipelines. Insert Glyphward’s pre-scan at the ingestion boundary — in all veterinary and animal health AI contexts, where the patient welfare, food safety, and insurance fraud consequences of adversarial image manipulation are categorically significant:
import asyncio
import base64
import hashlib
import os
import uuid
from enum import Enum
from pathlib import Path
import httpx
GLYPHWARD_API_KEY = os.environ["GLYPHWARD_API_KEY"]
GLYPHWARD_SCAN_URL = "https://glyphward.com/v1/scan"
# Veterinary and animal health AI — AVMA telemedicine guidelines,
# AAVLD diagnostic accreditation standards, USDA FSIS Residue Avoidance
# Program, AMDUCA 21 CFR Part 530, FDA CVM device guidance, state
# insurance fraud statutes, NAIC pet insurance model regulation.
# Threshold 55 — patient welfare, food safety (livestock), and insurance
# fraud consequences of adversarial false negatives exceed operational
# cost of human review of borderline flagged images.
THRESHOLD_VET = 55
class VeterinaryAIContext(str, Enum):
RADIOLOGY = "radiology" # IDEXX AI Radiometry, VetCT AI, Vet-AI
CYTOLOGY_PATHOLOGY = "cytology_pathology" # IDEXX AI cytology, Antech Diagnostics AI, Zoetis AI
LIVESTOCK_PHARMA = "livestock_pharma" # Zoetis AI livestock, Merck Animal Health AI, Elanco Poultry AI
PET_INSURANCE_CLAIM = "pet_insurance_claim" # Trupanion AI, Nationwide Pet, ASPCA, Lemonade Pet AI
async def scan_veterinary_image(
image_path: str | Path,
context: VeterinaryAIContext,
practice_id_hash: str, # SHA-256 of AVID practice ID or IDEXX account number
patient_hash: str, # SHA-256 of patient record ID — never raw patient data
case_ref: str, # e.g. "radiol_canine_thorax_2026Q2", "cyto_FNA_lymph_001"
client: httpx.AsyncClient,
) -> dict:
"""
Scan a veterinary or animal health AI image for adversarial injection
payloads before forwarding to veterinary radiology interpretation AI,
cytology and pathology classification AI, livestock pharmaceutical
compliance AI, or pet insurance claim assessment AI.
Raises AdversarialVeterinaryImageError if the Glyphward score meets or
exceeds the veterinary threshold (55).
"""
image_bytes = Path(image_path).read_bytes()
image_b64 = base64.b64encode(image_bytes).decode()
image_sha256 = hashlib.sha256(image_bytes).hexdigest()
scan_id = str(uuid.uuid4())
resp = await client.post(
GLYPHWARD_SCAN_URL,
headers={"Authorization": f"Bearer {GLYPHWARD_API_KEY}"},
json={
"image": image_b64,
"source": context.value,
"metadata": {
"vet_context": context.value,
"practice_id_hash": practice_id_hash,
"patient_hash": patient_hash,
"case_ref": case_ref,
"client_scan_id": scan_id,
"image_sha256": image_sha256,
},
},
timeout=10.0,
)
resp.raise_for_status()
result = resp.json()
audit_record = {
"practice_id_hash": practice_id_hash,
"patient_hash": patient_hash,
"case_ref": case_ref,
"vet_context": context.value,
"scan_id": result["scan_id"],
"client_scan_id": scan_id,
"image_sha256": image_sha256,
"score": result["score"],
"flagged_region": result.get("flagged_region"),
"threshold": THRESHOLD_VET,
"action": "blocked" if result["score"] >= THRESHOLD_VET else "allowed",
}
await write_vet_compliance_record(audit_record)
if result["score"] >= THRESHOLD_VET:
raise AdversarialVeterinaryImageError(
f"Veterinary AI image blocked [{context.value}]: "
f"scan_id={result['scan_id']} score={result['score']} "
f"practice_hash={practice_id_hash} ref={case_ref}"
)
return result
async def scan_cytology_batch(
slide_paths: list[Path],
practice_id_hash: str,
patient_hash: str,
case_ref: str,
) -> dict:
"""
Scan all digitised cytology or histopathology slide images for a
diagnostic case before loading into IDEXX AI cytology or Antech
Diagnostics AI pathology classification. All slides scanned with
CYTOLOGY_PATHOLOGY context (threshold 55).
"""
allowed, blocked, errors = [], [], []
async with httpx.AsyncClient() as client:
tasks = [
scan_veterinary_image(
p, VeterinaryAIContext.CYTOLOGY_PATHOLOGY,
practice_id_hash, patient_hash,
f"{case_ref}_slide{i:04d}", client,
)
for i, p in enumerate(slide_paths)
]
results = await asyncio.gather(*tasks, return_exceptions=True)
for path, result in zip(slide_paths, results):
if isinstance(result, AdversarialVeterinaryImageError):
blocked.append({"path": str(path), "error": str(result)})
elif isinstance(result, Exception):
errors.append({"path": str(path), "error": str(result)})
else:
allowed.append({"path": str(path), "scan_id": result["scan_id"]})
return {
"practice_id_hash": practice_id_hash,
"patient_hash": patient_hash,
"case_ref": case_ref,
"total": len(slide_paths),
"allowed": len(allowed),
"blocked": len(blocked),
"errors": len(errors),
"blocked_slides": blocked,
}
async def write_vet_compliance_record(record: dict) -> None:
"""Persist compliance audit record to practice/laboratory records system (stub)."""
import json, sys
print(json.dumps(record), file=sys.stderr)
class AdversarialVeterinaryImageError(Exception):
"""Raised when a veterinary AI image exceeds the adversarial injection threshold."""
pass
Call scan_veterinary_image() with VeterinaryAIContext.RADIOLOGY for digital radiograph JPEG/PNG exports and DICOM-derived image files before IDEXX AI Radiometry, VetCT AI, or Vet-AI radiograph interpretation — this is the highest patient welfare integration point in the small-animal diagnostic AI pipeline because an adversarially suppressed fracture or neoplastic mass finding defers the clinical intervention that determines the animal’s outcome. Call scan_cytology_batch() for digitised cytology and histopathology slide image sets before IDEXX Reference Laboratories AI cytology or Antech Diagnostics AI pathology classification — batch slide scanning prevents adversarial suppression of the malignancy morphological markers that would cause the AI preliminary classification to anchor the pathologist’s review toward a benign misdiagnosis. Call scan_veterinary_image() with VeterinaryAIContext.LIVESTOCK_PHARMA for all pharmaceutical compounding batch record photographs and drug label scans before Zoetis AI, Merck Animal Health AI, or Elanco AI pharmaceutical compliance extraction — livestock pharmaceutical compliance document scanning has direct USDA FSIS and AMDUCA exposure because the AI-extracted batch record values become the regulatory compliance record used to determine withdrawal time compliance for food-safety livestock. Call with VeterinaryAIContext.PET_INSURANCE_CLAIM for all injury, surgical site, and medical record page photographs submitted through Trupanion, Nationwide, ASPCA, or Lemonade Pet AI claim portals before AI severity classification — pet insurance claim photograph scanning prevents adversarial severity inflation that constitutes insurance fraud under state statutes in all 50 states. The Glyphward audit record should be retained as part of the veterinary practice’s or insurer’s compliance records for the applicable regulatory retention period. Get early access
Coverage matrix
| Control | Radiology AI injection | Cytology/pathology AI injection | Livestock pharma AI injection | Pet insurance claim AI injection |
|---|---|---|---|---|
| Text-only PI scanners (Lakera, LLM Guard) | No — adversarial pixel perturbations in digital radiograph JPEG/PNG images are invisible to text-based analysis | No — cytology slide scan pixel manipulation in cellular morphology regions is not detected by text-only scanning | No — livestock batch record document photograph pixel perturbations in drug concentration fields are not visible to text scanners | No — pet insurance claim injury photograph pixel manipulation in wound severity regions is not caught by text analysis |
| AVMA/AAVLD professional standards | AVMA telemedicine guidelines and state VCPR requirements apply to veterinarian conduct; do not prevent adversarial manipulation of AI radiograph image inputs before the veterinarian reviews the AI report | AAVLD accreditation standards require pathologist review of AI preliminary reports; adversarial AI output anchors pathologist review and may not be independently corrected even by a reviewing specialist | AMDUCA and 21 CFR Part 530 impose withdrawal time obligations on extralabel drug use; do not detect adversarial manipulation of compounding AI input photographs | NAIC pet insurance model regulation imposes claim documentation standards; does not prevent adversarial pixel manipulation of claim photographs before AI severity classification |
| Board-certified specialist review | Teleradiology specialist review of AI-generated preliminary reports can catch missed findings but an adversarially suppressed finding may not be flagged for specialist attention in the first place | Board-certified clinical pathologist review of AI cytology reports is required under AAVLD standards but adversarial AI preliminary classification anchors pathologist interpretation in high-volume settings | Veterinary pharmaceutical consultants reviewing batch records can detect discrepancies but adversarial AI extraction suppresses the discrepancy before manual review workflow is triggered | Human claim adjuster review of AI-generated severity assessments can detect inflated claims but adversarial AI classification redirects claims to automated approval queues that bypass human review |
| Glyphward | Yes — threshold 55; practice_id_hash audit trail; blocks adversarial radiograph images before IDEXX AI Radiometry, VetCT AI, or Vet-AI radiology interpretation | Yes — threshold 55; batch slide scan blocks adversarial cytology and histopathology slide images before IDEXX/Antech/Zoetis AI pathology malignancy classification | Yes — threshold 55; blocks adversarially crafted pharmaceutical batch record photographs before Zoetis/Merck/Elanco AI API concentration extraction and USDA FSIS compliance verification | Yes — threshold 55; blocks adversarially crafted pet insurance claim photographs before Trupanion/Nationwide/Lemonade AI claim severity classification and automated reimbursement tier assignment |
Frequently asked questions
How does adversarial manipulation of veterinary radiology AI differ from ordinary image compression artefacts or DICOM export errors, and why do existing quality assurance procedures not address the threat?
Ordinary image quality issues in veterinary digital radiography — JPEG compression artefacts that introduce blocking distortion at high-contrast tissue-air interfaces, DICOM-to-JPEG conversion that reduces bit depth and dynamic range in bone detail regions, and positioning motion blur that reduces diagnostic image quality in the thoracic region — are managed through veterinary radiology quality assurance procedures including image quality review at acquisition, retake protocols for non-diagnostic image quality, and DICOM image quality standards established by the AVMA and the American College of Veterinary Radiology (ACVR). These quality assurance procedures are designed for the equipment malfunction and technique error scenario: they evaluate whether the image contains sufficient diagnostic information for AI or radiologist interpretation, and they reject images that fall below diagnostic quality thresholds before AI processing begins. For IDEXX AI Radiometry, the image quality pre-screening step evaluates exposure, positioning, and motion artefact before the image is submitted to the AI radiology interpretation model.
Adversarial injection is a categorically different attack: the radiograph image is of full diagnostic quality — it passes all image quality pre-screening steps because the adversarial pixel perturbations are designed to be imperceptible to image quality metrics while causing the AI model to fail to detect or report specific abnormalities that are present in the image and visible to a radiologist reviewing the original image. The adversarial perturbations are not compression artefacts or technique errors; they are structured pixel-level modifications concentrated in the spatial regions of the image corresponding to the abnormality being suppressed, with perturbation magnitudes chosen to stay below the threshold of human perceptibility while exceeding the threshold of AI model sensitivity. Existing DICOM image quality standards (ACR-NEMA DICOM Part 14 display function calibration, ACVR veterinary imaging quality standards) do not include adversarial perturbation detection because they were designed before adversarial machine learning attacks were understood as a clinical risk. Preventing adversarial veterinary radiology AI manipulation requires a dedicated adversarial image scanner — such as Glyphward — that applies adversarial perturbation detection models at the image submission boundary, not image quality metrics that evaluate diagnostic sufficiency.
What is a veterinary practice’s professional and legal exposure when an adversarially manipulated cytology AI generates a benign classification for a malignant sample, and the animal’s cancer is diagnosed late as a result?
When an adversarially manipulated cytology AI generates a benign or non-diagnostic preliminary classification for a cytology sample that actually demonstrates malignancy, and the animal’s cancer is not diagnosed and staged until a later presentation — at which point the disease has progressed to a stage where treatment options are more limited and prognosis is worse — the veterinary practice faces professional and legal exposure through two principal frameworks. First, under state veterinary practice acts, the treating veterinarian has a professional duty to obtain or perform diagnostic workups that meet the standard of care for the presenting complaint and the clinical findings at the time of the examination. For a patient presenting with a palpable lymph node mass, a splenic mass identified on abdominal palpation, or a cutaneous mass with concerning clinical features, the standard of care includes cytological or histopathological assessment. If the cytology AI misclassifies the sample as benign and the veterinarian relies on the AI preliminary report without requesting board-certified clinical pathologist review of the digitised slide, the subsequent missed diagnosis may constitute a departure from the standard of care that supports a veterinary malpractice claim under state negligence law.
Second, the AAVLD accreditation standards for veterinary diagnostic laboratories require that AI-assisted preliminary cytology reports be reviewed by a board-certified clinical pathologist (Diplomate ACVP) before the report is released to the submitting veterinarian. If the adversarially manipulated AI preliminary classification anchors the pathologist’s review — causing the pathologist to spend less time reviewing the digitised slide because the AI preliminary classification characterises the sample as benign reactive tissue — the pathologist review may not independently identify the malignant cell population that was adversarially suppressed in the AI classification. In this scenario, both the veterinary diagnostic laboratory and the treating veterinarian may face professional standard-of-care claims. The veterinary diagnostic laboratory’s liability is distinct from the treating veterinarian’s liability: the laboratory owes an independent professional duty of diagnostic accuracy to the submitting veterinarian (and by extension to the patient) under the AAVLD accreditation standards and under state professional services liability law. Implementing Glyphward pre-scan for cytology slide image inputs to the IDEXX AI cytology or Antech Diagnostics AI platform — and retaining the Glyphward audit records as part of the laboratory’s quality management documentation — provides the laboratory with a documented data integrity verification measure that is relevant to any professional liability proceeding where the adequacy of the AI-assisted cytology workflow is at issue.
What USDA FSIS enforcement consequences does a livestock producer face when an adversarially manipulated pharmaceutical compliance AI generates an incorrect withdrawal time clearance from a manipulated batch record, and the animal tests positive for drug residues at slaughter?
When an adversarially manipulated pharmaceutical compliance AI generates an incorrect within-specification batch record extraction from a manipulated compounding batch record photograph — causing the livestock producer to calculate an insufficient withdrawal time for the actual drug concentration in the compounded product — and the animal subsequently tests positive for drug residues above the safe tolerance established under 21 CFR Part 556 at USDA FSIS slaughter inspection, the enforcement consequences cascade through several regulatory frameworks. First, under the USDA FSIS National Residue Program, the producer is identified as a residue violator and placed on the FSIS Residue Repeat Violator List, which triggers enhanced pre-slaughter testing protocols that increase testing frequency and extend the time and cost of the slaughter process for the producer’s subsequent animals. The producer must also submit a corrective action plan to the FSIS District Office demonstrating how the residue violation occurred and what steps have been taken to prevent recurrence — and the adversarial AI manipulation of the batch record is not a defence that eliminates the producer’s regulatory responsibility, because the producer is responsible for the accuracy of the pharmaceutical records used to calculate withdrawal times regardless of whether AI was used to process those records.
Second, under the AMDUCA (21 USC § 360b note) and 21 CFR Part 530, extralabel use of a veterinary pharmaceutical in a food-producing animal is subject to the prescribing veterinarian’s obligation to establish and communicate an extended withdrawal time that protects the public from drug residues in food. If the adversarially manipulated batch record causes the AI to extract a concentration value that the prescribing veterinarian uses to calculate an insufficient withdrawal time, the prescribing veterinarian may face regulatory action by the FDA CVM for failure to meet the extended withdrawal time calculation obligations under 21 CFR § 530.3. Third, under the FMIA (21 USC § 621), knowing introduction of adulterated meat — defined to include meat containing drug residues above established tolerances — into interstate commerce is a criminal offence. The “knowing” element of the FMIA criminal provision has been interpreted broadly, and a producer who continued to use a compounded pharmaceutical after the AI compliance platform flagged previous out-of-specification results — or who used an AI compliance platform without independent batch record verification controls — may face criminal exposure under the knowing introduction theory. Implementing Glyphward pre-scan for pharmaceutical batch record photograph inputs to Zoetis AI, Merck Animal Health AI, or Elanco AI compliance platforms — combined with independent laboratory verification of compounded API concentrations — provides the producer and the prescribing veterinarian with a documented data integrity chain for the batch record that is relevant to both the FSIS corrective action proceeding and any FDA CVM enforcement inquiry.
Further reading
- Indirect prompt injection via image — foundational attack pattern underlying all four veterinary AI injection surfaces; covers how adversarial pixel-level perturbations cause AI misclassification through image content manipulation without detectable visual artefacts visible to image quality screening.
- Prompt injection in healthcare AI — human healthcare AI with closely related diagnostic image injection vectors in radiology and pathology AI; covers HIPAA, FDA SaMD, and medical device adversarial image injection frameworks that parallel AVMA and AAVLD veterinary standards.
- Prompt injection in clinical trials and pharmaceutical AI — pharmaceutical and clinical research AI with overlapping drug batch record document injection vectors relevant to AMDUCA and FDA CVM livestock pharmaceutical compliance AI contexts.
- Prompt injection scanner for document AI — document AI scanning covering the broader class of scanned compliance record and laboratory result document injection vectors applicable to livestock pharmaceutical batch record and pet insurance claim document submission AI.
- Free tier — 10 scans/day, no card required — start scanning veterinary AI images at development volumes before committing to a production plan.